Patent thickets hinder biosimilar access, driving up costs and delaying affordable treatments. Discover legislative solutions to enhance competition and patient care.

The Silicon Valley company, a maker of chip design tools, said it took a one-time charge of $140.6 million related to ...

Transformative acquisition projected to generate up to an additional $7 million in annualized revenue in 2025 and further expand bottom line.Brings HACCP, GMP-certified, and FDA-registered manufacturi ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

Ripple has received a U.S. patent for its blockchain-based cross-border payment technology. The system enables instant ...

Tal Benschar discusses how the Eleventh Circuit ruled that a foreign intellectual property holding company can be subject to ...

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...

Platinum partner in IBM Partner Plus; Plans to collaborate on AI adoption across industriesBEAVERTON, Ore., July 29, 2025 (GLOBE NEWSWIRE) -- via IBN - Datavault AI Inc. (Nasdaq: DVLT), a leader in AI ...

The energy deal is a centerpiece of the trade agreement reached between Washington and Brussels on Sunday, which sets baseline U.S. tariffs at 15% for most European goods. The EU has agreed to buy ...

Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...

If the brand could replicate that in the world of AR Glasses, it would hold a considerable advantage over others in the field right off the bat. We've already seen Meta in partnership with a range of ...

Pill penalty disincentivizes R&D At a superficial level this results in somewhat lower drug prices, but it disincentivizes ...